By David Sterman
The S&P 500 is back near where it was a month ago. A surge into November was met by recent profit-taking as markets headed into the Thanksgiving holiday. In pullbacks like these, I like to scan the lists of losing stocks to see if any bargains get uncovered. I found three, all of which hit 52-week lows this week, and all of which are still solid long-term plays. The pullback in these names should set the stage for a much better 2011.
I recommended NuVasive (NUVA) two weeks ago as part of a paired trade play against Intuitive Surgical (ISRG). (Read A Unique Strategy to Play Offense and Defense in This Market).Since then, Intuitive Surgical has fallen roughly 10% while NuVasive has barely moved. That's logical: In a tough trading environment, the short end of paired trade is likely to play out better than the long end. Even as Intuitive Surgical comes back down to Earth, the real story here is NuVasive's eventual upward move. It won't come quickly -- few near-term positive catalysts exist --- but as 2011 unfolds investors are likely to see that NuVasive's recent quarterly missteps are more of a function of an unsettled health care environment than any company-specific troubles. As the dust settles, the fact that NuVasive's technology leads to improved patient outcomes and lower total health care costs is likely to again be the focus of health care insurers, and investors. Shares trade for less than 20 times next year's earnings for the first time in the company's history going back to 2004. A forward multiple closer to 30 still seems justified in the context of long-term growth, and that means 50% upside in 2011.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV